BDBM730241 US20250108139, Compound DB-19

SMILES O=C(O)CC[C@H](NC(=O)NC(CCCCNC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)c1ccc2c(c1)CCN(C(=O)CCC(=O)c1cc(NC(=O)CNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)cc(C(=O)CCC(=O)N3CCc4cc(C(=O)N[C@@H](Cc5ccc6ccccc6c5)C(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)ccc4C3)c1)C2)C(=O)O)C(=O)O

InChI Key InChIKey=HXDVXQJUKAMNRT-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 730241   

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730241(US20250108139, Compound DB-19)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
Go to US Patent